Martin G. Klatt, MD

Research Fellow
Martin G. Klatt, MD
My work is focused on MHC presented peptides. How can they be identified by mass spectrometry? How can their presentation be altered by certain drugs, e.g. CDK4/6 inhibitors or epigenetic modifiers? And what peptide-MHC complexes are ideal targets for immunotherapies, especially for TCR-mimic antibodies. When I am not in the lab I love to cook, sing and explore the playgrounds of NYC with my little family.
Office Fax
646-422-0640
Lab Phone
646-888-2205
Email
[email protected]
Dissertation
“Carcinogenesis of renal cell carcinoma reflected in HLA ligands: a novel approach for synergistic peptide vaccination design”
Start Year
2017
Education
MD from Eberhard Karls University in Tuebingen, Germany (2014)